Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Fuji
Fish and Richardson
Mallinckrodt
UBS
Julphar
Cipla
Deloitte
AstraZeneca

Generated: November 15, 2018

DrugPatentWatch Database Preview

Moxidectin - Generic Drug Details

« Back to Dashboard

What are the generic sources for moxidectin and what is the scope of moxidectin patent protection?

Moxidectin is the generic ingredient in one branded drug marketed by Mdgh and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for moxidectin.

Summary for moxidectin
Synonyms for moxidectin
(2aE,2'R,4E,4'E,5'S,6R,6'S,8E,11R,15S,17aR,20R,20aR,20bS)-6'-[(1E)-1,3-Dimethylbut-1-enyl]-20,20b-dihydroxy-4'-(methoxyimino)-5',6,8,19-tetramethyl-3',4',5',6,6',7,10,11,14,15,17a,20,20a,20b-tetradeca
(2aE,4E,5'R,6R,6'S,8E,11R,13S,15S,17aR,20R,20aR,20bS)-6'-((E)-1,3-Dimethyl-1-butenyl)-5',6,6',7,10,11,14,15,17a,20,20a,20b-dodecahydro-20,20b-dihydroxy-5',6,8,19-tetramethylspiro(11,15-methano-2H,13H,17H-furo(4,3,2-pq)(2,6)be
(6R,23E,25S)-5-O-Demethyl-28-deoxy-25-[(1E)-1,3-dimethyl-1-buten-1-yl]-6,28-epoxy-23-(methoxyimino)milbemycin B
(6R,25S)-5-O-Demethyl-28-deoxy-25-((E)-1,3-dimethyl-1-butenyl)-6,28-epoxy-23-oxomilbemycin B 23-(E)-(O-methyloxime)
[6R,23E,25S(E)]-5-O-Demethyl-28-deoxy-25-(1,3-dimethyl-1-butenyl)-6,28-epoxy-23-(methoxyimino)milbemycin B
113507-06-5
119718-45-5
119719-24-3
23-Methoxime-LL-F 28249|A
507M065
AB0021112
AB01563071_01
AC-27773
AKOS015895074
AKOS025401990
AN-33358
AOB6815
AS-16969
AS-17881
C37H53NO8
CAS-113507-06-5
CCG-213416
CHEMBL1867915
CHEMBL2104415
CL-301423
CL301423
CS-3080
Cydectin
D01ORS
D05084
DA-47802
DSSTox_CID_17577
DSSTox_GSID_37577
DSSTox_RID_79341
DTXSID5037577
EBD11520
Equest
EX-A496
HMS3264I15
HY-B0777
hydrospiro[2H,17H-11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-17-one
I06-0481
LS-172228
milbemycin B of milbemycin
Milbemycin B, 5-O-demethyl-28-deoxy-25-((1E)-1,3-dimethyl-1-butenyl)-6,28-epoxy-23-(methoxyimino)-, (6R,23E,25S)-
Milbemycin B, 5-O-demethyl-28-deoxy-25-(1,3-dimethyl-1-butenyl)-6,28-epoxy-23-(methoxyimino)-, (6R,23E,25S(E))-
Milbemycin B, 5-O-demethyl-28-deoxy-25-(1,3-dimethyl-1-butenyl)-6,28-epoxy-23-(methoxyimino)-, (6R,23Z,25S(E))-
MolPort-003-666-666
MolPort-023-220-662
Moxidectin (USAN/INN)
Moxidectin [USAN:INN:BAN]
Moxidectin [USAN:INN]
Moxidectin for system suitability, European Pharmacopoeia (EP) Reference Standard
Moxidectin for veterinary use impurity L [EP]
Moxidectin impurity L
Moxidectin, (23Z)-
Moxidectin, European Pharmacopoeia (EP) Reference Standard
Moxidectin, Pharmaceutical Secondary Standard; Certified Reference Material
Moxidectin, United States Pharmacopeia (USP) Reference Standard
Moxidectin, VETRANAL(TM), analytical standard
Moxidectina
Moxidectina [INN-Spanish]
Moxidectine
Moxidectine [INN-French]
Moxidectinum
Moxidectinum [INN-Latin]
NCGC00182083-02
NCGC00183118-01
NGU5H31YO9
NSC-760424
NSC760424
Pesticide4_Moxidectin_C37H53NO8_(1'R,2R,4Z,4'S,5S,6S,8'R,10'E,13'R,14'E,16'E,20'R,21'R,24'S)-21',24'-Dihydroxy-4-(methoxyimino)-5,11',13',22'-tetramethyl-6-[(2E)-4-methyl-2-penten-2-yl]-3,4,5,6-tetrahydro-2'H-spiro[pyran-2,6'
Pharmakon1600-01505394
ProHeart 6
Quest
SCHEMBL118876
SCHEMBL12554967
SCHEMBL13112872
SCHEMBL3462914
SR-05000002058
SR-05000002058-1
Tox21_113093
Tox21_113389
TYC529328W
UNII-NGU5H31YO9
UNII-TYC529328W
V2325
Vetdectin Oral Drench
YZBLFMPOMVTDJY-LSGXYNIPSA-N
YZBLFMPOMVTDJY-UBOCAARVSA-N
ZINC169649308
ZINC253476173

US Patents and Regulatory Information for moxidectin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mdgh MOXIDECTIN moxidectin TABLET;ORAL 210867-001 Jun 13, 2018 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mdgh MOXIDECTIN moxidectin TABLET;ORAL 210867-001 Jun 13, 2018 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Fuji
Fish and Richardson
Mallinckrodt
UBS
Julphar
Cipla
Deloitte
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.